Wilson's Disease in Bangladeshi Children: Analysis of 100 Cases

Md Rukunuzzaman1

  • 1Department of Paediatric Gastroenterology and Nutrition, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

Insights

Wilson's disease (WD) in children often presents with liver issues, with most cases showing chronic liver disease. Early jaundice in children over three warrants investigation for WD.

Area of Science:

  • Pediatric Hepatology
  • Neurology
  • Clinical Biochemistry

Background:

  • Wilson's disease (WD) is an inherited disorder of copper metabolism.
  • Early diagnosis and treatment are crucial to prevent severe liver and neurological damage.

Purpose of the Study:

  • To characterize the clinical and laboratory features of Wilson's disease in a pediatric cohort.
  • To identify key diagnostic indicators in children with suspected WD.

Main Methods:

  • A cross-sectional study involving 100 children (3-18 years) diagnosed with Wilson's disease.
  • Evaluation of clinical presentation, hepatic and neurological manifestations, and laboratory findings including serum and urinary copper levels.

Main Results:

  • The majority of pediatric WD patients presented with hepatic manifestations (69%), commonly chronic liver disease (42%).
  • Neurological and psychiatric symptoms were observed in some patients, with onset typically in the 10-15 year age group.
  • Key laboratory findings included Kayser-Fleischer rings (76%), elevated transaminases (85%), low serum ceruloplasmin (73%), and abnormal urinary copper excretion (81-92%).

Conclusions:

  • Wilson's disease in children frequently manifests with hepatic involvement, particularly chronic liver disease.
  • Investigating jaundice in children over three years of age for Wilson's disease is recommended.
  • Comprehensive clinical and laboratory assessment is vital for diagnosing pediatric Wilson's disease.
Abstract

Related Concept Videos

Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
172
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
380
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
346
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.7K